Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Processa Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Processa Pharmaceuticals

Processa Pharmaceuticals

Public

Processa Pharmaceuticals: Developing life-enhancing drugs for patients with high unmet medical needs since 2017.

HQ
Hanover, MD, US
Founded
2009
Overview
Compare
Fundraising
Employees

Processa Pharmaceuticals, founded in October 2017, aims to develop products that improve survival and quality of life for patients with high unmet medical needs. The company focuses on creating life-enhancing drugs, addressing critical gaps in the pharmaceutical market.

Processa Pharmaceuticals has made significant strides in drug development, contributing to advancements in patient care. Their work has garnered attention for its potential to address unmet medical needs, positioning the company as a key player in the pharmaceutical industry.

Processa Pharmaceuticals - Quick Facts

When was Processa Pharmaceuticals founded?

Processa Pharmaceuticals was founded in 2009.

Where is Processa Pharmaceuticals' headquarters located?

Processa Pharmaceuticals' headquarters is located in Hanover, MD, US.

When was Processa Pharmaceuticals' last funding round?

Processa Pharmaceuticals' most recent funding round was for $7M (USD) in January 2024.

How much has Processa Pharmaceuticals raised to-date?

As of Jan 26, 2024, Processa Pharmaceuticals has raised a total of $15.6M (USD).

How many employees does Processa Pharmaceuticals have?

Processa Pharmaceuticals has 14 employees as of Feb 6, 2024.

Processa Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
Unique IDs
  • ein: 451539785
  • secCik: 0001533743
  • ticker: PCSA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 27 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 333120Construction Machinery Manufacturing
  • 333900Other General Purpose Machinery Manufacturing
  • 333920Material Handling Equipment Manufacturing
  • 333923Overhead Traveling Crane, Hoist, and Monorail System Manufacturing
  • 336500Railroad Rolling Stock Manufacturing
  • 336510Railroad Rolling Stock Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 333000Machinery Manufacturing
  • 336000Transportation Equipment Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 333100Agriculture, Construction, and Mining Machinery Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3530Construction, Mining, And Materials Handling Machinery And Equipment
  • 3531Construction Machinery and Equipment
  • 3500Industrial And Commercial Machinery And Computer Equipment
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research